分叉病變市場報告（按類型（單支架、雙支架）、應用（冠狀血管、周邊血管）和地區分類）2025-2033

2024年全球分叉病變市場規模達25億美元。展望未來， IMARC Group預計到2033年市場規模將達到38億美元，2025-2033年期間的成長率（CAGR）為4.4%。

分叉病變是指冠狀動脈重要側支（SB）起源附近的狹窄。由於血流湍急和高切應力，分叉病變容易形成動脈粥狀硬化斑塊。分叉病變的治療手段包括分析、手術時間、X 光照射和長期追蹤等。此外，3D (3D) 血管攝影和多層 CT 可用於測量分叉角度。隨著設備、影像技術、輔助藥物治療和血管通路的進步，全球複雜分叉病變的治療正變得越來越可能。

分叉病變市場趨勢：

冠狀動脈疾病 (CAD) 發生率的顯著上升增加了分叉病變的風險。這是推動市場成長的關鍵因素之一。此外，創新設備的批准、保險覆蓋範圍的擴大以及成像方式的改進也加強了市場的成長。此外，老年人口的增加（他們更容易患上疾病）以及各國政府為報銷而採取的支持性措施正在支持市場的成長。日益成長的醫療旅遊業、對微創 (MI) 手術日益成長的需求以及不斷改善的醫療保健基礎設施是促進市場成長的其他一些因素。除此之外，正在進行的新型治療技術的研究也正在推動市場的發展。例如，研究人員正在研究 Szabo 雙支架技術對複雜分叉病變的有效性，這些病變具有較高的危及生命的風險，甚至會導致 SB 閉塞致命。此外，隨著熟練的醫療保健專業人員數量的增加，對支架和球囊進行廣泛的臨床試驗，預計將降低與分叉病變治療相關的風險並對市場產生積極影響。

本報告回答的關鍵問題

• 2024年全球分叉病變市場規模？ 2025-2033年全球分叉病變市場的預期成長率是多少？
• COVID-19 對全球分叉病變市場有何影響？
• 推動全球分叉病變市場發展的關鍵因素有哪些？
• 根據應用，全球分叉病變市場是如何分佈的？
• 全球分叉病變市場的主要區域有哪些？
• 全球分叉病變市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

• 研究目標
• 利害關係人
• 資料來源
  • 主要來源
  • 二手資料
• 市場評估
  • 自下而上的方法
  • 自上而下的方法
• 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球分叉病變市場

• 市場概況
• 市場表現
• COVID-19的影響
• 市場預測

第6章：市場細分：依類型

• 單支架
• 雙支架

第7章：市場區隔：依應用

• 冠狀血管
• 周邊血管

第8章：市場區隔：依地區

• 北美洲
  • 美國
  • 加拿大
• 亞太
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
• 中東和非洲

第9章：SWOT分析

第 10 章：價值鏈分析

第 11 章：波特五力分析

第 12 章：價格分析

第 13 章：競爭格局

• 市場結構
• 關鍵參與者
• 關鍵參與者簡介
  • Boston Scientific Corporation
  • Cardinal Health
  • Medtronic plc
  • Spectranetics (Koninklijke Philips NV)
  • Terumo Corporation

The global bifurcation lesions market size reached USD 2.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.8 Billion by 2033, exhibiting a growth rate (CAGR) of 4.4% during 2025-2033.

A bifurcation lesion refers to the narrowing of the coronary artery adjacent to the origin of a significant side branch (SB). It is prone to develop atherosclerotic plaque due to turbulent blood flow and high shear stress. It is treated using techniques like analysis, procedure duration, X-ray exposure, and long-term follow-up. Moreover, three-dimensional (3D) angiography and multi-slice computed tomography are utilized for measuring the bifurcation angles. With the advances in devices, imaging, adjunctive pharmacotherapy, and vascular access, the management of complex cases of bifurcation lesions is becoming possible worldwide.

Bifurcation Lesions Market Trends:

A significant rise in the occurrence of coronary artery disease (CAD) is increasing the risk of developing bifurcation lesions. This represents one of the key factors bolstering the market growth. Besides this, the approval of innovative devices, increasing insurance coverage, and improving imaging modalities are also strengthening the market growth. Moreover, the rising geriatric population, which is more likely to develop medical ailments, along with supportive initiatives undertaken by governments of various countries for reimbursement, is supporting the market growth. The increasing medical tourism, the escalating demand for minimally invasive (MI) procedures and the improving healthcare infrastructure are some of the other factors contributing to the growth of the market. Apart from this, the ongoing research on novel treatment techniques is driving the market. For instance, researchers are studying the effectiveness of the Szabo 2-stent technique for complex bifurcations lesions with high compromise risk or fatal consequences of SB occlusion. Furthermore, a wide range of clinical trials on stents and balloons, in confluence with the increasing number of skilled healthcare professionals, is anticipated to decrease risks associated with bifurcation lesions treatment and influence the market positively.

Key Market Segmentation:

Breakup by Types:

• One-Stent
• Two-Stent

Breakup by Application:

• Coronary Vascular
• Peripheral Vascular

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, Cardinal Health, Medtronic plc, Spectranetics (Koninklijke Philips N.V.) and Terumo Corporation.

Key Questions Answered in This Report

• 1.What was the size of the global bifurcation lesions market in 2024?
• 2.What is the expected growth rate of the global bifurcation lesions market during 2025-2033?
• 3.What has been the impact of COVID-19 on the global bifurcation lesions market?
• 4.What are the key factors driving the global bifurcation lesions market?
• 5.What is the breakup of the global bifurcation lesions market based on the application?
• 6.What are the key regions in the global bifurcation lesions market?
• 7.Who are the key players/companies in the global bifurcation lesions market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Bifurcation Lesions Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Types

• 6.1 One-Stent
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Two-Stent
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Application

• 7.1 Coronary Vascular
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Peripheral Vascular
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Boston Scientific Corporation
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
    • 13.3.1.4 SWOT Analysis
  • 13.3.2 Cardinal Health
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 Financials
    • 13.3.2.4 SWOT Analysis
  • 13.3.3 Medtronic plc
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
  • 13.3.4 Spectranetics (Koninklijke Philips N.V.)
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
  • 13.3.5 Terumo Corporation
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
    • 13.3.5.4 SWOT Analysis

List of Figures

• Figure 1: Global: Bifurcation Lesions Market: Major Drivers and Challenges
• Figure 2: Global: Bifurcation Lesions Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Bifurcation Lesions Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 4: Global: Bifurcation Lesions Market: Breakup by Types (in %), 2024
• Figure 5: Global: Bifurcation Lesions Market: Breakup by Application (in %), 2024
• Figure 6: Global: Bifurcation Lesions Market: Breakup by Region (in %), 2024
• Figure 7: Global: Bifurcation Lesions (One-Stent) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 8: Global: Bifurcation Lesions (One-Stent) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 9: Global: Bifurcation Lesions (Two-Stent) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 10: Global: Bifurcation Lesions (Two-Stent) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 11: Global: Bifurcation Lesions (Coronary Vascular) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Global: Bifurcation Lesions (Coronary Vascular) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Global: Bifurcation Lesions (Peripheral Vascular) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Bifurcation Lesions (Peripheral Vascular) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: North America: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: North America: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: United States: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: United States: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: Canada: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Canada: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: Asia-Pacific: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: Asia-Pacific: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: China: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: China: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Japan: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: Japan: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: India: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: India: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: South Korea: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: South Korea: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: Australia: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: Australia: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: Indonesia: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: Indonesia: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: Others: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 36: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 37: Europe: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 38: Europe: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: Germany: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: Germany: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 41: France: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 42: France: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: United Kingdom: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: United Kingdom: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 45: Italy: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 46: Italy: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 47: Spain: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 48: Spain: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 49: Russia: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 50: Russia: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 51: Others: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 52: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 53: Latin America: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 54: Latin America: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 55: Brazil: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 56: Brazil: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 57: Mexico: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 58: Mexico: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 59: Others: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 60: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 61: Middle East and Africa: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
• Figure 62: Middle East and Africa: Bifurcation Lesions Market: Breakup by Country (in %), 2024
• Figure 63: Middle East and Africa: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 64: Global: Bifurcation Lesions Industry: SWOT Analysis
• Figure 65: Global: Bifurcation Lesions Industry: Value Chain Analysis
• Figure 66: Global: Bifurcation Lesions Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Bifurcation Lesions Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Bifurcation Lesions Market Forecast: Breakup by Types (in Million USD), 2025-2033
• Table 3: Global: Bifurcation Lesions Market Forecast: Breakup by Application (in Million USD), 2025-2033
• Table 4: Global: Bifurcation Lesions Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 5: Global: Bifurcation Lesions Market: Competitive Structure
• Table 6: Global: Bifurcation Lesions Market: Key Players